The evaluation of Ki67 expression in EGI-1 xenografts (Figure 4A and Supplementary Figure S1) demonstrated that all treatments induced a significant decrease of tumor proliferation (p <0.0001), although this phenomenon is more evident in the presence of Trametinib and of the drug combination. The gene discussed is MKI67; the disease is neoplasm.